Bio-Rad Laboratories, Inc. (BIO.B)
NYSE: BIO.B · Real-Time Price · USD
360.06
0.00 (0.00%)
Oct 26, 2026, 4:00 PM EDT - Market closed
Bio-Rad Laboratories Market Cap
Bio-Rad Laboratories has a market cap or net worth of $9.75 billion as of October 26, 2026. Its market cap has increased by 6.40% in one year.
Market Cap
9.75B
Enterprise Value
9.50B
1-Year Change
6.40%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since October 26, 2021, Bio-Rad Laboratories's market cap has decreased from $23.13B to $9.75B, a decrease of -57.85%. That is a compound annual growth rate of -15.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 9.75B | 19.39% |
| Dec 31, 2025 | 8.17B | -11.01% |
| Dec 31, 2024 | 9.18B | -1.27% |
| Dec 29, 2023 | 9.30B | -25.52% |
| Dec 30, 2022 | 12.48B | -44.81% |
| Dec 31, 2021 | 22.62B | -2.24% |
| Oct 26, 2021 | 23.13B | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zimmer Biomet Holdings | 18.80B |
| Smith & Nephew | 12.91B |
| Penumbra | 12.78B |
| Globus Medical | 10.93B |
| Glaukos | 10.55B |
| Insulet | 10.33B |
| Bio-Rad Laboratories | 9.89B |
| 10x Genomics | 9.32B |